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Abstract
Background: Dynamic changes to the epigenome play a critical role in establishing and maintaining cellular
phenotype during differentiation, but little is known about the normal methylomic differences that occur between
functionally distinct areas of the brain. We characterized intra- and inter-individual methylomic variation across
whole blood and multiple regions of the brain from multiple donors.
Results: Distinct tissue-specific patterns of DNA methylation were identified, with a highly significant over-
representation of tissue-specific differentially methylated regions (TS-DMRs) observed at intragenic CpG islands and
low CG density promoters. A large proportion of TS-DMRs were located near genes that are differentially expressed
across brain regions. TS-DMRs were significantly enriched near genes involved in functional pathways related to
neurodevelopment and neuronal differentiation, including BDNF, BMP4, CACNA1A, CACA1AF, EOMES, NGFR, NUMBL,
PCDH9, SLIT1, SLITRK1 and SHANK3. Although between-tissue variation in DNA methylation was found to greatly
exceed between-individual differences within any one tissue, we found that some inter-individual variation was
reflected across brain and blood, indicating that peripheral tissues may have some utility in epidemiological studies
of complex neurobiological phenotypes.
Conclusions: This study reinforces the importance of DNA methylation in regulating cellular phenotype across
tissues, and highlights genomic patterns of epigenetic variation across functionally distinct regions of the brain,
providing a resource for the epigenetics and neuroscience research communities.
Background
DNA methylation is a key epigenetic mechanism
involved in the developmental regulation of gene expres-
sion [1], but the tissue-specific nature of DNA methyla-
tion has not been fully characterized at a genomic level.
Epigenetic processes control several neurobiological and
cognitive processes, including neurogenesis and brain
development [2], neuronal activity [3], learning and
memory [4], drug addiction [5], neurodegeneration [6],
and circadian rhythm [7]. The importance of DNA
methylation in normal brain function and development
is exemplified by the neurodevelopmental deficits
associated with mutations in the methyl CpG binding
protein 2 gene (MECP2) in Rett syndrome [8], and the
aberrant DNA methylation signatures observed in neu-
ropsychiatric disorders, including schizophrenia and
bipolar disorder [9]. Although gene expression analyses
have highlighted clear transcriptomic differences across
brain regions [10-12], current studies of tissue-specific
DNA methylation in the brain have assessed only a
small percentage of CpG sites in the human genome
[13], and none has taken an unbiased methylome-wide
approach across multiple brain regions and blood
obtained from the same individuals. Little is known,
therefore, about normal methylomic differences between
functionally distinct areas of the brain and how these
correspond to patterns observed in easily accessible per-
ipheral tissues such as blood. In this study we used
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methylated DNA immunoprecipitation combined with
ultra-deep sequencing (MeDIP-seq) to profile the
methylomic landscape across multiple dissected brain
regions and blood obtained from multiple individuals.
We present annotated maps of the brain methylome,
representing a unique resource for the genomics and
neuroscience research communities, identifying key
regions of the genome characterized by functionally
relevant tissue-specific DNA methylation.
Results and discussion
Methylomic profiling across brain and blood
Our primary methylomic profiling experiments used
multiple dissected brain regions (inferior frontal gyrus,
middle frontal gyrus, entorhinal cortex, superior tem-
poral gyrus of the temporal cortex, visual cortex, and
cerebellum) from post-mortem brain samples obtained
from individuals free of any neuropathology and neu-
ropsychiatric disease. From a subset of these indivi-
duals, whole blood samples were also obtained
longitudinally prior to death. A detailed list of the pri-
mary samples used in this study is given in Supple-
mentary Table 1 in Additional file 1. Of these, 21
tissue samples from three individuals (two female, one
male) were initially assessed using ultra-deep paired-
end MeDIP-seq (see Materials and methods). After
stringent quality control (Supplementary Figure 1 in
Additional file 1), an average of >70.4 million uniquely
mapped 50 bp reads were obtained from each of the
21 samples (Supplementary Table 2 in Additional file
1); to our knowledge, this represents the largest
between-individual and cross-tissue DNA methylation
dataset yet produced. To generate an estimate of actual
DNA methylation from our MeDIP-seq data, we used
the MEDIPS analysis package [14] to control for local
CpG density and generate DNA methylation scores for
overlapping 500 bp bins across the genome. Bisulfite
pyrosequencing was used to verify DNA methylation
estimates at selected regions of the genome, and exam-
ine base pair-specific levels of DNA methylation across
nominated regions in additional brain and blood sam-
ples. Normalized raw MeDIP-seq reads and MEDIPS-
estimated absolute DNA methylation values for each
tissue/individual combination are available as a
resource for download and browsing as UCSC tracks
from our laboratory website [15]. The data are also
being integrated into the Human Epigenome Atlas
[16,17] as part of the regular data release by NIH Epi-
genomics Roadmap Initiative [18].
Genome-wide DNA methylation across cortex, cerebellum
and peripheral blood is highly tissue-specific
As expected, canonical genic DNA methylation profiles
do not differ across samples or tissue types, with overall
low average DNA methylation around the immediate
transcription start site, high levels of DNA methylation
across the gene body, and more subtle hypomethylation
being observed at the 3’ end of genes (Supplementary
Figure 2 in Additional file 1), confirming previous obser-
vations [19]. Genome-wide, however, there are striking
tissue-specific differences in DNA methylation, with a
clear hierarchical distinction between the six cortical
regions, cerebellum and blood (Figure 1a, b). These
broad differences reflect the known developmental path-
ways of the three tissues; blood cells originate from the
mesoderm, while cells of the central nervous system are
ectodermic. Within the brain, the cerebellum develops
from the metencephalon, whilst the cerebral cortex
develops from the most anterior part of the neural plate
(the telencephalon). The cortex itself is subdivided into
numerous functionally distinct anatomical regions, spe-
cializing in sensory, motor, and association tasks.
DNA methylation varies across different functionally
annotated regions of the genome
We defined feature sets spanning i) all annotated CpG
islands (CGIs), sub-typed by location (gene promoter,
intragenic, 3’ UTR, and intergenic) as described pre-
viously [19], ii) CGI shores (spanning 2,000 bp up- and
downstream of each CGI), and iii) all annotated coding
sequences (CDSs). We also examined tissue-specific pat-
terns of DNA methylation across gene promoters
defined by low, medium and high CG content (LCPs,
ICPs, and HCPs, respectively) [20]. BED files of the fea-
ture annotations used in this study (CGIs, CGI shores,
CDSs, LCPs, ICPs, and HCPs) are available for down-
load from our laboratory webpage [15]. DNA methyla-
tion across each feature was quantified using both
normalized MeDIP-seq read counts and MEDIPS scores;
Figure 2a shows the average DNA methylation levels for
each feature type. As described previously [21], CGIs are
significantly hypomethylated compared to CGI shores
and the gene body, with no overall difference in canoni-
cal methylation patterns between tissues or individuals.
There is, however, considerable heterogeneity in DNA
methylation across different categories of CGI, depen-
dent upon genomic location, with promoter CGIs being
significantly hypomethylated in comparison to intra-
genic, 3’ UTR, and intergenic CGIs. CGI shores, on the
other hand, do not vary significantly as a function of
genomic location. Although the majority of promoters
(approximately 60%) are associated with CGIs, not all
promoter regions are hypomethylated; promoter methy-
lation is inversely correlated with CG density, with LCPs
being the most methylated of any feature type tested. In
contrast, HCPs (which overlap considerably with promo-
ter CGIs) are hypomethylated relative to the other
features.
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DNA methylation differs significantly between tissues
across all annotated feature types
We next examined tissue- and brain region-specific
DNA methylation in the context of annotated gene
features to identify regions of the genome harboring
tissue-specific differentially methylated regions (TS-
DMRs). Due to the overall similarity between the six
cortical regions, we initially focused on gross differ-
ences between cortex, cerebellum and blood. Cross-tis-
sue normalized MeDIP-seq data for all 65,535
annotated features can be downloaded from our
laboratory website [15]. For each broad category of fea-
ture, hierarchical clustering of the MeDIP-seq data can
clearly distinguish between tissue types (Supplementary
Figure 3 in Additional file 1). The top 50 variably
methylated annotated features across cortex, cerebel-
lum and blood are listed in Supplementary Table 3 in
Additional file 1. Using Illumina 450 K HumanMethy-
lation microarray data obtained from matched cerebel-
lum, frontal cortex, and whole blood samples from 90
individuals being assessed by our group as part of an
ongoing clinical epigenetics study (Mill et al., unpub-
lished data), we were able to confirm that the vast
majority of these features are true TS-DMRs (Supple-
mentary Table 4 in Additional file 1); 74% of the 206
probes mapping to the broad genomic regions covered
by these features were characterized by false discovery
rate-significant intra-individual between-tissue DNA
methylation differences in the direction predicted by
our MeDIP-seq data.
Ingenuity Pathway Analysis (IPA) of the most vari-
able features (defined as those with a coefficient of
variance (CV) >1 across the three tissue types) high-
lights a highly significant enrichment of functional
pathways involved in regulating developmental gene
expression (P = 8.83 × 10-25), organismal development
(P = 1.37 × 10-20), and tissue differentiation (P = 2.34
× 10-20) (Supplementary Figure 4 in Additional file 1).
Of note, given the origins of the samples used in this
analysis, it is interesting that the primary tissue-speci-
fic functional pathways enriched in the list of TS-
DMRs are nervous system development and function
(P = 4.60 × 10-21) and hematological system develop-
ment and function (P = 3.61 × 10-8), indicating that
epigenetic differences are likely to be associated with
significant phenotypic differences. Although TS-DMRs
are distributed across all feature types, there are
marked differences in the between-tissue correlation
of DNA methylation across each of the broad feature
categories we examined, with CGIs being more corre-
lated across cortex, cerebellum and blood than CGI
shores or CDSs (Figure 2b).
Figure 1 Methylomic profiling across multiple brain areas and blood from a cohort of individuals highlights clear tissue-specific
differences in DNA methylation. (a, b) DNA methylation was calculated from ultra-deep MeDIP-seq data using 500 bp bins across the
genome, and the relationship between tissues determined by Pearson correlation (a) and unsupervised hierarchical clustering (b). BA, Brodmann
area; Ent Ctx, entorhinal cortex; STG, superior temporal gyrus; Vis Ctx, visual cortex.
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TS-DMRs across brain regions are associated with stable
gene expression differences and are highly enriched for
functionally relevant neurobiological pathways
Within the brain, the top 50 differentially methylated
annotated features between cortical and cerebellum
samples are listed in Supplementary Table 5 in Addi-
tional file 1. Strikingly, many of these DMRs are asso-
ciated with genes of known relevance to cortical and/or
cerebellar development and function, including
PPP2R2B (encoding a phosphatase implicated in the
negative control of cell growth and division, whose dis-
ruption causes cerebellar ataxia [22]), JAKMIP1/MAR-
LIN1 (encoding a RNA-binding protein that associates
with GABA receptors [23]), EOMES (encoding a tran-
scriptional activator that plays a crucial role in brain
development, controlling the proliferation of intermedi-
ate progenitor cells and their progeny in the cerebral
cortex [24]), GPMB6 (encoding a proteolipid widely
expressed in neurons and in oligodendrocytes [25]), and
GRM4 (encoding a metabotropic glutamate receptor
with a distinct distribution in the brain, primarily
expressed in cerebellar granule cells [26]). Furthermore,
IPA of the top within-brain variable DMRs
(differentiating cortex from cerebellum) highlights a pri-
mary network involved in nervous system development
and function (Supplementary Figure 5 in Additional file
1), with highly significant enrichment of developmen-
tally relevant pathways, including neurogenesis (P = 1.76
× 10-19), the guidance of neurites (P = 2.11 × 10-12),
development of the cerebellum (P = 8.49 × 10-5) and
development of the cortex (P = 1.11 × 10-4) (Supple-
mentary Table 6 in Additional file 1).
We next used RNA extracted from matched cerebel-
lum and frontal cortex (Brodmann area (BA)9) samples,
obtained from an independent cohort of 42 additional
individuals, to assess tissue-specific expression levels for
detectable gene transcripts located in the vicinity of the
top 50 cortex-cerebellum DMRs. The majority (82%) of
these DMRs are mirrored by significant (P < 0.05) gene
expression differences between cerebellum and frontal
cortex (Supplementary Table 7 in Additional file 1),
with 61% of genes being represented by at least one
probe with a highly significant (P < 1 × 10-10) expression
difference across the two brain regions. Interestingly,
DNA methylation at these DMRs is not always nega-
tively correlated with gene expression; EOMES, for
Figure 2 Although DNA methylation at CGIs is relatively conserved across tissues, intragenic CGIs are dramatically over-represented
and promoter CGIs under-represented in the most tissue-variable CGIs. (a) Average DNA methylation values calculated by MEDIPS from
MeDIP-seq data for all annotated gene features: CGIs (yellow), CGI shores (blue), gene promoters (red) and CDSs (green). DNA methylation is
lower in promoter CGIs compared to intragenic, 3’ UTR and intergenic CGIs. CGI shores are characterized by higher DNA methylation than CGIs,
with less location-dependent variation. Promoter DNA methylation shows a strong inverse correlation with GC density, with LCPs showing a
higher average level of DNA methylation than CDSs. Error bars represent standard error of the mean. (b) Although TS-DMRs are distributed
across all feature types, there are marked differences in the between-tissue correlation of DNA methylation across each of the broad feature
categories we examined, with CGIs being more correlated across cortex, cerebellum and blood than CGI shores or CDSs. (c, d) There is a highly
significant enrichment of intragenic CGIs (P = 2 × 10-102) in analyses of CGI DMRs differentiating blood, cortex and cerebellum (c), and an even
more dramatic enrichment (P = 1 × 10-246) in comparisons between cortex and cerebellum (d). EXP, expected; OBS, observed.
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example, shows highly significant elevated expression in
the cerebellum compared to the frontal cortex (log2
expression values = 9.25 versus 6.46, P = 1.90 × 10-33).
An analysis of publically available gene expression data
[12] confirms many of these gene expression differences
and demonstrates that many of the cortex-cerebellum
DMRs are associated with developmentally stable gene
expression differences between the brain regions (Sup-
plementary Figure 6 in Additional file 1). This further
supports the notion that the TS-DMRs identified here
mediate functionally important differences in the cellular
transcriptome.
DNA methylation differs across functionally discrete
regions of the cerebral cortex
Although for all features tested the six cortical regions
formed a tight cluster, distinct from both cerebellum and
blood (Figure 1a, b), we were interested to see if we could
identify DMRs that could distinguish between them. Sup-
plementary Table 8 in Additional file 1 lists the 50 most
variably methylated features across samples obtained
from the frontal cortex (BA8, BA9, and BA10), entorhinal
cortex, superior temporal gyrus, and visual cortex. While
the magnitude of within-cortex variation is clearly lower
than observed between average cortex and either cerebel-
lum or blood, there are some noticeable region-specific
patterns of DNA methylation, particularly in the visual
cortex. This list of DMRs contains a striking number of
genes implicated in brain function related to the cortex
and neurodevelopment, including CACNA1A and CAC-
NA1F (calcium-channel genes involved in neuronal
growth and development and controlling the release of
neurotransmitters [27]), GALNT9 (a brain-specific O-gly-
cosylase [28]), SLC8A2/NCX2 (a sodium/calcium exchan-
ger that has been shown to be important in synaptic
plasticity and cortical development [29]), NUMBL
(encoding a protein that maintains progenitor cells dur-
ing cortical neurogenesis [30]), and GRIK5 (a receptor for
the excitory neurotansmitter glutamate [31]). IPA on loci
associated with the top 500 across-cortex variably methy-
lated features highlights an interactive network of genes
involved in neurodevelopment and function (Supplemen-
tary Figure 7 in Additional file 1), with a significant
enrichment for functional pathways associated with neu-
rogenesis and neuronal function, including many directly
related to development of the cortex, such as ‘forebrain
development’ (P = 6.15 × 10-7) (Supplementary Table 9
in Additional file 1).
Although DNA methylation at promoter CGIs is strongly
conserved across brain areas and blood, tissue-specific
DNA methylation is particularly striking at intragenic CGIs
The top 50 differentially methylated CGIs between cor-
tex, cerebellum and blood are listed in Supplementary
Table 10 in Additional file 1. Of particular interest is
the observation that a CGI associated with BMP4, which
encodes a protein mediating differentiation of the ecto-
derm into the nervous plate [32], is one of the strongest
CGI DMRs between blood and brain (cortex and cere-
bellum). Also showing highly variable patterns of DNA
methylation between brain tissues and blood are CGIs
associated with other key neurodevelopmental genes,
including BDNF (encoding a neurotrophic factor with
an important role in neurodevelopment and neurogen-
esis [33]) and SLITRK1 (encoding an integral membrane
protein involved in neurite outgrowth [34]). IPA of the
most variable (CV >1) blood versus brain CGIs reveals a
highly significant enrichment of functional pathways
involved in basic tissue development, including loci reg-
ulating both neurogenesis (P = 9.88 × 10-14) and hema-
topoiesis (P = 4.59 × 10-8) (Supplementary Table 11 in
Additional file 1). Bisulfite pyrosequencing was used to
verify selected CGI DMRs, and examine base pair-speci-
fic levels of DNA methylation across the nominated
regions in additional samples. These included the top
differentially methylated CGI, located within the
JMJD2B/KDM4B gene, encoding a histone demethylase
that specifically demethylates histone H3 lysine 9, and
highly ranked DMRs associated with the neurodevelop-
mental genes BDNF and EOMES. We observed a highly
significant correlation between our MeDIP-seq and pyr-
osequencing data (correlation = 0.58, P = 7.07 × 10-13;
Supplementary Figure 8 in Additional file 1), with highly
significant between-tissue DNA methylation differences,
confirming the MeDIP-seq data, being observed for all
tested bisulfite-PCR amplicons (Figure 3).
We observed a highly significant (c2 P-value = 2 × 10-
102) over-representation (observed/expected (o/e) = 1.73)
of intragenic CGIs amongst these TS-DMRs, with a
complementary under-representation (o/e = 0.43) of
promoter CGIs (Figure 2c) and a highly significant dif-
ference in average CV between these two classes of CGI
(promoter CGI mean CV = 0.35, intragenic CGI mean
CV = 0.60, P < 1 × 10-10). Promoter CGIs are also sig-
nificantly less-variable across tissues compared to 3’
CGIs (mean CV = 0.59) and intergenic CGIs (mean CV
= 0.50). A comparison of the most differentially methy-
lated CGIs between cerebellum and cortex, which again
are significantly enriched for pathways related to brain
development, neurogenesis and functional specialization
in the brain (Supplementary Table 12 in Additional file
1), highlights an even more dramatic over-representa-
tion of intragenic CGIs (o/e = 2.37) and under-represen-
tation of promoter CGIs (o/e = 0.09) (c2 P-value = 1 ×
10-246; Figure 2d). To explore the functional organiza-
tion of DNA methylation at intragenic CGIs across cor-
tex, cerebellum and blood, we used weighted gene co-
methylation network analysis [35] to identify modules of
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Figure 3 Verification and replication of MeDIP-seq data for three top-ranked CGI DMRs. (a, b) Tissue-specific DNA methylation across an
intragenic CGI in the JMJD2B/KDM4B gene. (a) MeDIP-seq analysis shows this region is hypermethylated in blood DNA compared to cortex and
cerebellum (the red bar depicts the region subsequently analyzed by bisulfite pyrosequencing). (b) Pyrosequencing data for this region in an
extended sample set confirm significant tissue-specific methylation patterns (P = 2 × 10-8). (c, d) Tissue-specific DNA methylation across a CGI in
the promoter of the EOMES gene. (c) MeDIP-seq analysis shows this region is hypermethylated in cerebellum DNA compared to cortex and
blood. (d) Pyrosequencing data for this region in an extended sample set confirm significant tissue-specific methylation patterns (P = 2 × 10-5).
(e, f) Tissue-specific DNA methylation across an intragenic CGI in the BDNF gene. (e) MeDIP-seq analysis shows this region is hypermethylated in
blood DNA compared to cortex and cerebellum from the same individuals. (f) Pyrosequencing data for this region in an extended sample set
confirm significant tissue-specific methylation patterns (P = 4 × 10-9). Error bars represent standard error of the mean.
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co-methylated features via unsupervised hierarchical
clustering on the basis of high topological overlap (see
Materials and methods). Six modules were identified
with clear tissue-specific patterns, demonstrating that
the methylome is organized into modules of co-methy-
lated features (Figure 4a). The strongest tissue-specific
module (blue), composed of approximately 1,000 intra-
genic CGIs that were hypomethylated in the cortex
compared to cerebellum and blood (Pearson correlation
= -0.98, P = 4 × 10-5), representing a network of genes
involved in nervous system development and function
(Figure 4b) and significantly enriched for functional
pathways, including neurogenesis (P = 2.47 × 10-25) and
the differentiation of neurons (P = 6.18 × 10-18). Analy-
sis of the top 5% of genes ranked by module member-
ship using publically available gene expression datasets
by GeneMania [36] showed that 58.9% are also coex-
pressed, indicating that the co-methylation networks
identified here map onto functional gene coexpression
networks. Furthermore, genes in this module are signifi-
cantly enriched in relevant gene expression modules
from published brain gene expression datasets (Supple-
mentary Table 13 in Additional file 1). A role for differ-
ential DNA methylation at intragenic CGIs across
different cell types in the mouse hematopoietic lineage
has been recently reported [37], and it has been sug-
gested that these features may regulate transcription
from alternative promoters across specific cell types
[19].
On average, CGI shores show more tissue-specific DNA
methylation than CGIs, but do not vary by genic location
CGI shores have been previously shown to harbor phe-
notypically relevant tissue-specific patterns of DNA
methylation [21]. Compared to CGIs, we found CGI
shores to be significantly more variable across brain
areas and blood (average CGI CV = 0.46, average CGI
shore CV = 0.57, P < 1 × 10-10), with DNA methylation
noticeably less correlated across tissues, especially
between brain (cortex and cerebellum) and blood (Fig-
ure 2b). Unlike for CGIs, however, the location of CGI
shores makes little impact on their variability across tis-
sues with no over-representation of intragenically
located features (Supplementary Figure 9 in Additional
file 1). The top 50 differentially methylated CGI shores
between cortex, cerebellum and blood are listed in Sup-
plementary Table 14 in Additional file 1. Strikingly,
many are associated with genes of known neurobiologi-
cal function, including PCDH9 (encoding a cadherin-
related neuronal receptor that localizes to synaptic junc-
tions, involved in specific neuronal connections and sig-
nal transduction [38]), NGFR (encoding the receptor for
nerve growth factor, with widespread effects on neuro-
development [39]), AUTS2 (encoding the autism
susceptibility candidate 2, a nuclear protein expressed in
developing brain regions [40]), SHANK3 (encoding a
scaffold protein involved in the structural and functional
organization of the post-synaptic density and also impli-
cated in autism [41]), and SLIT1 (encoding a protein
with a key role in cortical development and synaptogen-
esis [42]). IPA of the most variable CGI shores again
reveals a highly significant enrichment for functional
pathways involved in nervous system function and
development (Supplementary Table 15 in Additional file
1). Bisulfite pyrosequencing was used to confirm and
replicate the two top-ranked CGI shore DMRs, which
are highly significantly hypermethylated specifically in
the cerebellum, flanking a hypomethylated intergenic
CGI on chromosome 7 (Supplementary Figure 1 in
Additional file 10). Again, our pyrosequencing data were
significantly correlated with the MEDIPS scores across
each of the three amplicons spanning this region (left
shore, correlation = 0.76, P = 5.58 × 10-5; CGI, correla-
tion = 0.80, P = 1.18 × 10-5; right shore, correlation =
0.82, P = 4.36 × 10-6), confirming the validity of the
methylome data.
Low CG content promoters are also characterized by
widespread tissue-specific DNA methylation across brain
regions and blood
Our CGI data concur with the notion that CpG-rich
promoters (that is, HCPs) are predominantly hypo-
methylated and associated with ubiquitously expressed
house-keeping genes [20,43]. We next decided to com-
pare HCP methylation with that seen in LCPs; recent
methylomic analyses of other tissues indicate that differ-
ential DNA methylation across LCPs is associated with
tissue-specific gene expression in somatic cells [20]. Our
data provide strong evidence to support this notion, and
like intragenic CGIs, LCPs appear to be a major location
for tissue-specific DNA methylation signatures across
brain regions and blood. While hierarchical clustering of
both HCP and LCP DNA methylation can distinguish
between tissues, the Euclidian distance between tissues
is much larger in the case of LCPs (Figure 5a). Principal
components analysis of our MeDIP-seq data shows a
much stronger tissue classification based upon LCP
methylation (Figure 5b), and correlation analyses show
that while HCP methylation is largely conserved across
tissues (reflecting the pattern seen for promoter CGIs),
the correlation of LCP methylation across tissues is
much lower.
Between-individual differences in DNA methylation are
correlated across brain and blood
Because aberrant DNA methylation is being increasingly
implicated in the etiology of complex disease phenotypes,
including several mental health disorders [44], a key
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Figure 4 Weighted gene co-methylation network analysis of DNA methylation at intragenic CGIs. (a) Dendrograms produced by average
linkage hierarchical clustering of intragenic CGIs on the basis of topological overlap. Modules of co-methylated loci were assigned colors as
indicated by the horizontal bar beneath each dendrogram. The ‘blue’ module was strongly negatively co-methylated (r2 = -0.98, P = 4 × 10-5) in
cortex. (b) IPA on the genes associated with the blue module highlighted a network involved in nervous system development and function.
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question in epigenetic epidemiology concerns the extent
to which easily accessible peripheral tissues (for example,
whole blood) can be used to ask questions about inter-
individual phenotypic variation manifest in inaccessible
tissues such as the brain [45,46]. Our use of brain tissue
and blood obtained pre-mortem from the same individuals
enabled us to investigate the extent to which between-
individual methylomic variation in the blood is reflected
across the cortex and cerebellum. Comparing MeDIP-seq
data from blood, cortex and cerebellum, we observe that
inter-individual DNA methylation differences are highest
in blood and lowest in the cortex, with a highly significant
difference in variability across tissues (P < 0.001; Figure
6a). The pattern of relative inter-individual variability by
feature is, however, the same across tissues, with non-pro-
moter CGIs showing a significantly higher level of
between-individual DNA methylation differences than
other features. Strikingly, there is a significant correlation
between individual DNA methylation differences in the
blood and those in brain tissue (cortex and cerebellum)
from the same two individuals (Figure 6b), with the most
reproducible pattern of blood-detected individual differ-
ences observed in the cerebellum (correlation = 0.76, P <
0.001) and slightly less correlation between blood and cor-
tex (correlation = 0.66, P < 0.001). Although replicate
DNA samples from each individual were assessed using
high-resolution SNP arrays to identify potential structural
variants and minimize the confounding effect of inter-indi-
vidual copy-number variations (CNVs) that could manifest
as MeDIP-seq read differences (see Materials and meth-
ods), the influence of genomic differences between indivi-
duals cannot be fully excluded. Supplementary Table 16 in
Additional file 1 lists the top 50 between-individual differ-
ences in DNA methylation identified in blood between the
two female MeDIP-seq blood samples and lists the corre-
sponding methylation scores from cortex and cerebellum
from the same individuals. Interestingly, while many fea-
tures show near-identical between-individual patterns
across all three tissues, some examples of blood-identified
variation are only detected in either the cortex or cerebel-
lum. Given recent reports by us and others of widespread
genotype-associated allele-specific DNA methylation [47],
it is likely that many of these between-individual DNA
methylation differences are mediated by DNA sequence
variation that is common across tissues, although other
mechanisms such as epigenetic changes occurring early in
development before complete tissue differentiation could
also be important.
Conclusions
We used MeDIP-seq to undertake the first genomic
characterization of intra- and inter-individual variation
Figure 5 DNA methylation across LCPs is strongly associated
with tissue type. (a) MEDIPS scores across both HCPs and LCPs
can be used to accurately cluster samples by tissue type, but the
strength of clustering, indicated by Pearson dissimilarity on the y-
axis, is much higher in LCPs. (b, c) This pattern is reflected in three-
factor PCA plots (b) and correlation analyses (c), with LCPs
demonstrating stronger tissue-specific patterns of DNA methylation
than HCPs.
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in DNA methylation across multiple regions of the
human brain and an easily accessible peripheral tissue
(whole blood). In summary, we show that between-tis-
sue variation in DNA methylation greatly exceeds
between-individual differences within any one tissue,
with clear hierarchical differences in DNA methylation
across specific brain areas, and between brain and
blood. Interestingly, we observe that TS-DMRs are
strikingly under-represented in classic promoter CGIs,
being located primarily in intragenic CGIs and LCPs.
These TS-DMRs are dramatically enriched for genes
known to be involved in brain development and neuro-
biological function, forming networks of co-methylated
loci that define the cellular phenotype. Finally,
although inter-individual differences in DNA methyla-
tion are dwarfed by tissue-specific variation, and abso-
lute levels of DNA methylation at specific loci clearly
differs between cortex, cerebellum and blood, we
observe that some between-individual variation in
DNA methylation is correlated between brain regions
and blood.
To our knowledge, this study represents the most
comprehensive cross-tissue inter-individual assessment
of the methylomic landscape of the brain yet underta-
ken. The data generated in this project are available as a
resource to the genomics research community; anno-
tated UCSC tracks can be downloaded from our labora-
tory website [15], and the raw data are being integrated
into the Human Epigenome Atlas [16] as part of the
regular data release by NIH Epigenomics Roadmap
Initiative. A primary goal of global research initiatives
such as the International Human Epigenome Consor-
tium and the NIH Epigenomics Roadmap is to create
high-resolution reference epigenome maps across multi-
ple human tissue and cell types that will expedite the
application of epigenomic technologies to studies of
human health and disease [18]. In this regard, and given
increasing evidence supporting a role for epigenetic
Figure 6 Between-individual variation in DNA methylation is often correlated between blood and brain. (a) Between-individual variation
in DNA methylation is highest in blood and lowest in the cortex. All tissues show a similarly significant (ANOVA P < 0.001) distribution of
variability across features, with the greatest between-individual variation occurring in non-promoter CGIs. Scores represent the mean difference
in normalized MeDIP-seq read density between individual 1 and 2 for each of the feature categories. Error bars represent standard error of the
mean. Features 1 to 4 = promoter, intragenic, 3’, and intergenic CGIs; features 4 to 8 = promoter, intragenic, 3’, and intergenic CGI shores;
feature 9 = CDS; features 10 to 12 = HCPs, ICPs, and LCPs. (b) Between-individual differences in DNA methylation observed in blood are
significantly (P < 0.001) correlated with differences observed in the cerebellum (correlation = 0.76) and cortex (correlation = 0.66) from the same
individuals. Scores represent the mean difference in normalized MeDIP-seq read density between individual 1 and 2 for each of the quantified
features.
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disruption in neuropsychiatric disease, a unique aspect
of this study was our use of blood and multiple brain
regions from the same individuals, enabling us to
address questions about the extent to which easily
accessible peripheral tissues can be used to ask ques-
tions about inter-individual phenotypic variation mani-
fest in inaccessible tissues such as the brain.
In addition to creating reference maps of DNA methy-
lation across multiple brain regions and blood, we have
identified key regions of the genome that are character-
ized by tissue-specific patterns of DNA methylation. Of
note, TS-DMRs were significantly enriched near genes
involved in functional pathways related to neurodevelop-
ment and neuronal differentiation, including BDNF,
BMP4, CACNA1A, CACA1AF, EOMES, NGFR, NUMBL,
PCDH9, SLIT1, SLITRK1, and SHANK3. Although DNA
methylation at promoter CGIs is largely conserved
across tissues, reflecting data from other studies, we find
striking evidence that intragenic CGIs are a primary
location for TS-DMRs. This builds on recent data high-
lighting cell type-specific DNA methylation at intragenic
CGIs in the immune system [37], and evidence that
these features may regulate transcription from alterna-
tive promoters across specific cell types [19]. Our data
highlight LCPs as another region characterized by con-
siderable cross-tissue epigenetic variation; again these
data support recent methylomic analyses of other tis-
sues, indicating that differential DNA methylation across
LCPs is associated with tissue-specific gene expression
in somatic cells [20]. Given the striking enrichment of
tissue-relevant pathways and gene sets amongst the loci
associated with the TS-DMRs we have identified, and
the observation that many of these genes are differen-
tially expressed across brain regions (Supplementary
Table 7 and Supplementary Figure 6 in Additional file
1), it is likely that they mediate functionally relevant dif-
ferences in the cellular transcriptome.
There are several limitations to this study. First,
although it represents one of the largest cross-tissue
methylomic analyses performed to date, the number of
individuals profiled in our initial MeDIP-seq screen was
relatively small. Our successful verification and replica-
tion experiments (using bisulfite pyrosequencing and the
Illumina 450 K array), combined with our gene expres-
sion data, in larger number of samples, however, high-
lights the validity of the between-tissue differences we
observe. Second, the samples used in our initial MeDIP-
seq screen were all obtained from donors >75 years old
and may not fully represent patterns of DNA methyla-
tion earlier in life. However, our observation of highly
significant gene expression differences corresponding to
the top 50 cortex-cerebellum DMRs in a younger cohort
of samples (average age = 62 ± 18 years) suggests that
many of the tissue-specific differences observed are
developmentally stable, resulting in functional differ-
ences at an earlier age. Future work should focus on
identifying developmental trajectories of epigenetic
change across multiple tissues.
In summary, this study reinforces the importance of
DNA methylation in regulating cellular phenotype
across tissues, and highlights genomic patterns of epige-




Post-mortem brain samples from nine elderly control
individuals (free of neuropathological and neuropsychia-
tric disease) were obtained from the MRC London Neu-
rodegenerative Diseases Brain Bank. Multiple brain
regions were dissected from each sample by a trained
neuropathologist, snap-frozen and stored at -80°C.
Genomic DNA was isolated from each dissected brain
region from each sample using a standard phenol-
chloroform extraction method, and tested for degrada-
tion and purity prior to analysis. From a subset of indi-
viduals whole blood samples were also obtained
longitudinally prior to death, and DNA extracted using
a standard phenol-chloroform method. A detailed list of
the samples used for methylomic profiling in this study
is given in Supplementary Table 1 in Additional file 1.
An independent set of matched frontal cortex and cere-
bellum samples (average age = 62 ± 18 years, 33%
female) for gene expression analysis was obtained from
42 additional individuals provided by the London Neu-
rodegenerative Diseases Brain Bank.
Methylated DNA immunoprecipitation and sequencing
DNA was fragmented using a Covaris sonication system
and sequencing libraries were prepared from 5 μg frag-
mented genomic DNA. End repair, <A> base addition
and adaptor ligation steps were performed using Illumi-
na’s Paired-End DNA Sample Prep kit. Adaptor-ligated
DNA was immunoprecipitated by anti-5mC using a
commercial antibody (Diagenode, Liège, Belgium), and
MeDIP products were validated by quantitative PCR.
MeDIP DNA was purified with ZYMO DNA Clean &
Concentrator-5 columns, and amplified using adaptor-
mediated PCR. DNA fragments between 220 and 320 bp
in size were gel-excised, and amplification quality and
quantity were evaluated by Agilent BioAnalyzer analysis.
The libraries were subjected to highly parallel 50 bp
paired-end sequencing on the Illumina Hi-Seq platform.
Sequencing quality control and alignment
From the raw fastq files, Illumina quality scores were
converted into Sanger Phred quality scores using MAQ
[48]. Quality control was performed on the raw
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sequence data using FastQC [49]. Supplementary Figure
1 in Additional file 1 shows FastQC output for one
representative sample highlighting the high quality
sequencing data obtained. Alignment to hg18 was per-
formed using the Burrows-Wheeler algorithm.
Correcting for local CpG densities
The MEDIPS package [14] was used to calculate methy-
lation scores by incorporating a coupling factor based
on local CpG density. Bin sizes of 500 bp were defined
across the genome, with an overlap of 250 bp. The
number of CpGs within the maximal defined distance
around the genomic bin was calculated and a calibration
curve determined relative to the dependency of local
MeDIP-seq signal intensities and local CpG densities.
DMR calling across known features using normalized read
counts
Mapped reads were also quantified using SeqMonk
(Babraham Institute, Cambridge, UK). BED files of the
feature annotations used in this study (CGIs, CGI
shores, CDS, LCPs, ICPs, and HCPs) are available for
download from our laboratory webpage [15]. Read-
depth scores were generated for each feature, normal-
ized for total read count and feature length. For each
feature, the CV across tissues/samples was calculated
(Standard deviation/(Mean + 1)) and ranked.
Weighted gene co-methylation network analysis
We employed weighted gene co-methylation network
analysis [35,50,51] as described in R [52] to find
weighted signed co-methylation networks (modules) in
the cortex, cerebellum and peripheral blood using log
transformed MEDIPS scores. For each genomic feature
we performed hierarchical clustering of the samples,
based on Pearson correlation, and mapped the final
sample dendrogram to three traits (cortex, cerebellum
and blood) to describe the sample-trait relationship.
For each genomic feature type we performed hierarchi-
cal clustering of the topological overlap matrix. Leaves
of the tree were grouped into modules, which is a clus-
ter of highly co-methylated genomic locations (GL).
After finding the modules, the next step was to
describe the relationship between modules and each
tissue (that is, cortex, cerebellum and peripheral
blood). For this we calculated the Pearson correlation
coefficient for the module representative also known as
module eigengene (ME), which is the first principal
component of each module’s methylation profile, and
each trait. The GL-trait relation (or gene significance
GS if thinking in terms of gene expression) was
defined as (the absolute value of) the correlation
between the GL methylation profile and the trait. For
each module, we also calculated a quantitative measure
of module membership as (the absolute value of) the
correlation of the ME and the GL methylation profile.
This measure allows us to assess the similarity between
a module’s DNA methylation profile and DNA methy-
lation at a genomic location.
Bisulfite pyrosequencing analysis
Genomic DNA (0.5 μg), extracted from dissected brain
samples and blood (Supplementary Table 1 in Addi-
tional file 1), was bisulfite converted using the EZ 96-
DNA methylation kit (Zymo Research, Irvine, CA, USA)
following the manufacturer’s standard protocol. Fully
methylated and unmethylated samples were included
throughout the experimental procedure as assay con-
trols. Pyrosequencing assays were designed using the
Pyromark Assay Design Software (Qiagen, Crawley, UK).
Bisulfite-PCR amplification was performed in duplicate
using Hot Star Taq DNA polymerase (Qiagen, UK) and
optimized cycling conditions. Pyrosequencing was per-
formed using the Pyromark Q24 (Qiagen, UK). A full
list of bisulfite PCR and sequencing primers is given in
Supplementary Table 17 in Additional file 1.
Gene expression analysis
RNA was extracted from matched cerebellum and
frontal cortex samples from 42 LBBND donors using
the Trizol extraction method and purified using an
RNeasy Mini Kit with DNase I digestion (Qiagen, UK)
according to the manufacturer’s instructions. RNA was
tested for purity and degradation using an Agilent
2100 Bioanalyzer and RNA 6000 Nano kit (Agilent
Technologies, Wokingham, UK). RNA was biotinylated
and amplified using the Illumina TotalPrep™ RNA
Amplification kit (Life Technologies, Paisley, UK).
Gene expression was assessed using Illumina
HumanHT-12 v4 microarrays (Illumina, San Diego,
California, USA) according to the standard manufac-
turer’s protocol. Following scanning, signal intensities
for each probe were extracted using Illumina Geno-
meStudio and imported into R using the Lumi package
within Bioconductor. Probes relating to the top 50 cer-
ebellum-cortex DMRs were tested for expression dif-
ferences between cerebellum and cortex.
Genotyping arrays and CNV analysis
For the individuals assessed by MeDIP-seq, Affymetrix
SNP 6.0 arrays (Affymetrix, High Wycombe, UK) were
used to genotype samples from two tissues according to
the manufacturers’ standard protocol. CNVs were iden-
tified using the PennCNV program [53]. Briefly, this
implements a hidden Markov model that integrates mul-
tiple sources of information to infer CNV calls for indi-
vidual genotyped samples. CNVs were stringently called
by comparing the duplicate arrays from each individual.
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Data availability
The methylomic data generated in this project is avail-
able for browsing as UCSC Genome Browser tracks
from our laboratory website [15]. Raw data have also
been deposited into the Human Epigenome Atlas
[16,17] and will be integrated into this resource as part
of the next data release by NIH Epigenomics Roadmap
Initiative.
Additional material
Additional file 1: Supplementary figures and tables. This file contains
Supplementary Figures 1 to 10 and Supplementary Tables 1 to 17.
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